期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

PI3K／Akt通路和帕金森病 被引量：2

PI3K/Akt Pathway and Parkinson＇s Disease
原文传递
导出
摘要 帕金森病是常见的神经系统退行性疾病之一，许多研究表明帕金森病的发病与细胞凋亡有关，而多种信号传导途径参与了细胞凋亡的调控。本义主要对PI3K／Akt通路与帕金森病凋亡的关系予以综述。 Parkinson＇s disease （PD） is one of the most common neurodegenerative disease. Many studies have shown that apop- tosis has taken place in the pathogenesis of PD and a variety of signal transduction pathways are involved in the regulation of apoptosis. The relationship between PI3K/Akt pathway and apoptosis of PD will be discussed in this paper.
作者 张玲玲 陈建宗
机构地区 第四军医大学西京医院中医药研究中心
出处 《国际老年医学杂志》 2011年第2期74-77,共4页 International Journal of Geriatrics
关键词 帕金森病 细胞凋亡 PI3K/AKT通路 Parkinson＇s disease Apoptosis PI3K/Akt pathway
分类号 R737.31 [医药卫生—肿瘤]
  • 相关文献

参考文献31

  • 1Dauer W, Przedborski S. Parkinsong Disease: mecha- nisms and models [J]. Neuron, 2003, 39 (6): 889 - 909.
  • 2Lev N, Melamed sons disease [ J] E, Often D. Progress in cology and Biological PsychiauT - 250. Apoptosis and Parkin- Neuro - Psychopharma 2003, 27 (2) : 245.
  • 3Cantley LC. The Phosphoinositide 3 - Kinase pathway [J]. Science, 2002, 296 (5573): 1655-1657.
  • 4Manning BD, Cantley LC. AKT/PKB signaling: navi- gating downstream [J]. Cell, 2007, 129 (7): 1261 - 1274.
  • 5Timmons S, Coakley MF, Moloney AM, et al. Akt signal transduction dysfunction in Parkinson "s disease [ J]. Neurosci Lett, 2009, 467 ( 1 ) : 30 - 35.
  • 6Dudek H, Datta SR, Frank TF, et al. Regulation of neuronal survival by the serine- threonine protein kinase Akt [J]. Science, 1997, 275 (5300): 661- 665.
  • 7Sugimoto Y, Whitman M, Cantley LC, et al. Evidence that the Rous sarcoma virus transforming gene product phosphorylates phosphatidylinositol and diacylglycerol [J]. PNAS, 1984, 81 (7): 2117-2121.
  • 8Ward SG, Finan P. Isoform specific phosphoinositide 3- kinase inhibitors as therapeutic agents [ J ]. Curt Opin Pharmaeol, 2003, 3 (4): 426-434.
  • 9Engelman JA, Luo J, Cantley LC. The evolution of phosphatidylinositol 3 - kinases as regulators of growth and metabolism [ J ]. Nature Reviews Genetics, 2006, 7 (8): 606-619.
  • 10Xiromerisiou G, Hadjigeorgiou GM, Papadimitriou A, et al. Association between AKT1 gene and Parkinsong disease: a protective haplotype [ J ]. Neurosei Lett, 2008, 436 (2): 232-234.

二级参考文献14

  • 1张宇红,陈生弟,李江林,杨红旗,郑汭,周海燕,王刚,陆国强.红景天甙促进帕金森病模型小鼠表达内源性胶质细胞源性神经营养因子蛋白保护多巴胺能神经元[J].中华神经科杂志,2006,39(8):540-543. 被引量：20
  • 2朱红灿,段东晓,王晓东,张璐,许予明,张博爱,邢莹.3-硝基丙酸预处理对大鼠局灶性脑缺血Bcl-2和Bax mRNA表达的影响[J].临床神经病学杂志,2006,19(6):432-434. 被引量：2
  • 3Cheng CM, Reinhardt RR, Lee WH, et al. Insulin-like growth factor 1 regulates developing brain glucose metabolism[J].Proc Natl Acad Sci USA, 2000, 97:10236.
  • 4Daftary SS, Gore AC. IGF1 in the brain as a regulator of reproductive neuroendocrine function[J].Exp Biol Med (Maywood),2005, 230:292.
  • 5Jiang H, Guo W, Liang X, et al. Both the establishment and the maintenance of neuronal polarity require active mechanisms: critical roles of GSK3beta and its upstream regulators[J].Cell,2005, 120:123.
  • 6Huang TJ, Verkhratsky A, Fernyhough P. Insulin enhances mitochondrial inner membrane potential and increases ATP levels through phosphoinositide 3-kinase in adult sensory neurons[J].Mol Cell Neurosci,2005, 28:42.
  • 7Datta SR, Brunet A, Greenberg ME, et al. Cellular survival: a play in three Akts [J].Genes & Develop, 1999, 13 : 2905.
  • 8Koyasu S. The role of PI3K in immune cells[J].Nature Immun, 2003, 4: 313.
  • 9Cantley LC. The phosphoinositide 3kinase pathway[J].Science, 2002, 296: 1655.
  • 10Fang X, Yu SX, Lu Y, et al. Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A[J].Proc Natl Acad Sci USA,2000,97:11960.

共引文献12

同被引文献19

  • 1杨梅,孙圣刚.镁对帕金森病大鼠黑质多巴胺神经元的影响[J].临床神经病学杂志,2008,21(6):437-440. 被引量：7
  • 2Toulouse A, Sullivan AM.. Progress in Parkinson's disease - where do we stand [J]. Prog Neurobiol, 2008, 85(4): 376-392.
  • 3Henchcliffe C, Severt WL. Disease modification in Parkinson's disease [J]. Drugs Aging, 2011, 28(8): 605-615.
  • 4PaxinosG,WatsonC.诸葛启钏,译.大鼠脑立体定位图谱[M].3版.北京:人民卫生出版社,2005:18.21.
  • 5Sinchez-Iglesias S, Rey P, M6ndez-Alvarez E, et al. Time-course of brain oxidative damage caused by intrastriatal administration of 6-hydroxydopamine in a rat model of Parkin- son's disease [J]. Neurochcm Res, 2007, 32(1): 99-105.
  • 6Liu Q, Kou JP, Yu BY. Ginsenoside Rgl protects against hydro- gen peroxide-induced cell death in PC12 cells via inhibiting NF-nB activation [J]. Neurochem Int, 2011, 58(1): 119-125.
  • 7Duty S, Jenner P. Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the dis- ease [J]. Br J Pharmacol, 2011, 164(4): 1357-1391.
  • 8Iancu R, Mohapel P, Brundin P, et al. Behavioral characteriza- tion of a unilateral 6-OHDA-lesion model of Parkinson's dis- ease in mice [J]. Behav Brain Res, 2005, 162(1): 1-10.
  • 9Przedborski S, Ischiropoulos H. Reactive oxygen and nitrogen species: weapons of neuronal destruction in models of Parkin- son's disease [J]. Antioxid Redox Signal, 2005, 7(5-6): 685-693.
  • 10Hald A, Lotharius J. Oxidative stress and inflammation in Par- kinson's disease: is there a causal link? [J]. Exp Neurol, 2005, 193(2): 279-290.

引证文献2

二级引证文献7

国际老年医学杂志
2011年 第2期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部